Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis.
Stefano PiasericoAndrea ContiFrancesco MessinaAlberto MeneguzzoGiulia OdoriciFrancesco BellinatoPaolo GisondiPublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2021)